SMAD3 and prostate cancer: The NR2C2 also increased prostate cancer invasion by altering TGFβR2/p-Smad3 signalling by decreasing miR-373-3p expression [88] and further, promotes prostate cancer metastasis through upregulation of CCL2/CCR2 signalling [89].